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Background: Sub-clinical hypothyroid dysfunction, a relatively understudied disorder in the Kingdom of Saudi
Arabia (KSA), has significant clinical implications if not properly monitored. Also from KSA, more than 50% of the
population suffer from hypovitaminosis D (<50 nmol/l). In this cross-sectional case-control study, we described the
differences and associations in the metabolic patterns of adult Saudis with and without hypothyroid dysfunction in
relation to their vitamin D status, PTH, calcium and lipid profile.
Methods: A total of 94 consenting adult Saudis [52 controls (without subclinical hypothyroidism), 42 cases
(previously diagnosed subjects)] were included in this cross-sectional study. Anthropometrics were obtained and
fasting blood samples were taken for ascertaining lipid and thyroid profile, as well as measuring PTH, 25(OH)
vitamin D and calcium.
Results: Cases had a significantly higher body mass index than the controls (p < 0.001). Circulating triglycerides was
also significantly higher in cases than the controls (p = 0.001). A significant positive association between HDL-
cholesterol and PTH (R = 0.56; p = 0.001), as well as a negative and modestly significant negative association
between LDL-cholesterol and PTH (R = - 20.0; p = 0.04) were observed. FT3 was inversely associated with circulating
25 (OH) vitamin D (R = -0.25; p = 0.01).
Conclusions: Patients with hypothyroid dysfunction possess several cardiometabolic risk factors that include
obesity and dyslipidemia. The association between PTH and cholesterol levels as well as the inverse association
between vitamin D status and FT3 needs to be reassessed prospectively on a larger scale to confirm these findings.
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Thyroid diseases are one of the more commonly en-
countered endocrine disorders in the Kingdom of Saudi
Arabia (KSA), next to diabetes mellitus (DM) [1]. While
current demographics point to less alarming prevalence
of thyroid dysfunction, certain populations such as
children with Down syndrome appear to manifest condi-
tions related to thyroid dysfunction [2]. In the Middle* Correspondence: aldaghri2011@gmail.com
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reproduction in any medium, provided the orEast in general, thyroid dysfunction, specifically subclinical
hypothyroid dysfunction, is a relatively understudied field
as compared to other metabolic disorders such as obesity
and insulin resistance. In a recent study, Bahammam and
colleagues observed that subclinical hypothyroid dysfunc-
tion was prevalent among Saudi patients suffering from
obstructive sleep apnea (OSA), with an estimated 1 out of
10 OSA patients harboring the condition [3]. Granted that
hypothyroid dysfunction is not as endemic as the previ-
ously mentioned disorders, it nevertheless deserves atten-
tion as it can lead to serious repercussions if left ignored.
Several studies point to an association between thyroid
diseases, particularly Grave’s disease and vitamin D statusl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.





Age (years) 36.1 ± 8.1 35.5 ± 10.1 0.75
Gender (M/F) 6/46 3/39
Body Mass Index (kg/m2) 27.8 ± 3.9 32.3 ± 6.8 <0.001
Triglycerides (mmol/l) 1.2 ± 0.26 1.9 ± 0.46 0.001
Total Cholesterol (mmol/l) 5.1 ± 0.80 5.2 ± 1.0 0.56
LDL-Cholesterol (mmol/l) 3.9 ± 0.88 3.9 ± 0.87 0.99
HDL-Cholesterol (mmol/l) 0.90 ± 0.37 0.88 ± 0.30 0.78
Iodine (μg/l) 119.5 ± 35.9 97.6 ± 38.5 0.009
TSH (mIU/l)# 2.4 (1.6, 3.3) 3.7 (1.5, 7.6) 0.04
FT3 (pmol/l) 6.0 ± 1.3 4.8 ± 1.2 <0.001
FT4 (pmol/l) 17.2 ± 1.3 17.5 ± 1.2 0.80
TPOAb (U/ml) # 17.7 (14.1, 25.0) 164.9 (15.8, 582.9) 0.001
PTH (pg/ml) 5.3 ± 1.5 8.0 ± 1.2 0.15
Albumin (g/l) 33.8 ± 5.4 36.5 ± 6.8 0.03
Corrected Ca (mmol/l) 2.4 ± 0.23 2.1 ± 0.18 < 0.001
Ca (mmol/l) 2.5 ± 0.19 2.1 ± 0.45 0.002
25 (OH) Vitamin D (nmol/l) 18.3 ± 1.5 37.3 ± 1.9 < 0.001
Note: # denotes non-Gaussian distribution and presented as median
(interquartile range); p-value significant at < 0.05.
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Middle East [4-6]. In this cross-sectional case-control
study, we describe the differences and associations in
the metabolic patterns of adult Saudis with and without
subclinical hypothyroid dysfunction in relation to lipid
and calcium metabolism in an attempt to stimulate




A total of 94 consenting adult Saudis [52 control (6
males; 46 females), 42 cases (3 males, 39 females)] were
included in this cross-sectional study. All subjects were
recruited at the Endocrinology Unit of King Fahad
Medical City, Riyadh Saudi Arabia. Adult Saudis aged
20-50, who are known cases of subclinical hypothyroid
dysfunction based on previous clinical assessment (ele-
vated TSH with normal FT4 levels), medications taken
and laboratory tests with no complications were in-
cluded. Control subjects were those who tested negative
for subclinical hypothyroid dysfunction with no history
of thyroid medications. Non-Saudis and pregnant wo-
men as well as children were excluded. Written and in-
formed consent were secured prior to inclusion. Ethical
approval was obtained from the Institutional Review
Board of King Fahad Medical City, Riyadh, KSA.
Anthropometrics
Anthropometric parameters were obtained while the
subject was standing erect and barefoot. Height and
weight were determined using standardized conventional
methods. Body mass index (BMI) was calculated using
the formula: weight in kilograms (kg) divided by height
in squared meters (m2).
Blood measurements
Blood (≈ 10cc) was withdrawn after an overnight fast (>
10 hours). Serum calcium was measured using standard
analytical techniques (Konelab, Finland). Fasting blood
lipids which included triglycerides, total, HDL- and LDL-
cholesterol as well as calcium were measured routinely
using a chemical analyzer (Konelab, Finland). Serum TSH,
FT3, and FT4 were estimated using commercially avail-
able kits by Roche Elecsys Modular Analytics Cobas e411
utilizing electrochemiluminescence immunoassay (Roche
Diagnostics, Mannheim, Germany). TSH upper normal
limit for males is 3.69 μIU/ml and 3.94 μIU/ml for
females. Intact PTH and 25(OH)D were measured by spe-
cific ELISAs in accordance with the instructions provided
by the manufacturer (IDS, Tyne & Wear, UK). 25(OH)
vitamin D has been the preferred metabolite for the meas-
urement of vitamin D status instead of 1, 25(OH)D, and
remains the basis for the diagnosis of vitamin D deficiency[7]. The inter- and intra-assay variabilities were 5.8% and
3.4% respectively for the intact PTH ELISA, 5.3% and
4.6% respectively for the 25(OH)D ELISA. Anti-thyroid
peroxidase (TPO) antibodies (Ab) were also measured
using commercially available ELISA kits (Bio-Line S.A,
Brussels, Belgium) with a sensitivity of 1.4 U/ml (intra-
assay variability 6.9%; inter-assay variability 13.4%).
Data analysis
Data was analyzed using the Statistical Package for the
Social Sciences (SPSS) version 16.5 (Chicago, IL, USA).
Frequencies were presented as N and continuous variables
if normal were presented as mean ± standard deviation
and median (inter-quartile range) for variables with non-
normal distribution. For group comparisons (controls
versus cases), independent T-test if normally distributed
continuous variables, and Mann-Whitney U-test for vari-
ables with non-Gaussian distribution were utilized. Signifi-
cance set at p < 0.05.
Results
Table 1 shows the general characteristics of both cases
and controls. There was no significant difference in the
mean age of both groups. Subjects with thyroid dysfunc-
tion had a significantly higher body mass index than
controls (p < 0.001). Circulating triglycerides were also
Table 2 Correlation coefficients (R) of Lipids to thyroid function tests, PTH and vitamin D adjusted for age and BMI
TSH FT3 FT4 PTH Iodine TPO Ab Vitamin D
Total Cholesterol (mmol/l) -0.05 -0.02 -0.06 -0.04 0.05 0.03 -0.02
HDL-Cholesterol (mmol/l) -0.12 -0.13 -0.13 0.56** -0.04 0.08 -0.04
Triglycerides (mmol/l) 0.12 0.04 -0.10 -0.16 -0.09 0.01 -0.19
LDL-Cholesterol (mmol/l) -0.04 0.02 0.003 -0.20* 0.08 0.001 0.04
Note: * denotes significance at < 0.05; ** denotes significance at < 0.01; p-value significant at < 0.05.
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(p = 0.001). The rest of the lipid parameters (Total, LDL-
and HDL-cholesterol) were not significant. Among the
thyroid tests, median TSH and median TPO Ab were sig-
nificantly higher in the cases (consistent with Hashimoto’s
Thyroiditis) who also had a significantly lower mean FT3
and iodine than the controls (p values 0.03, 0.001, 0.009
and < 0.001, respectively). Only 2 subjects had TPOAb
levels below 1.7 U/ml (cases). Mean FT4 was similar in
both cases and controls. Lastly, mean serum calcium as
well as corrected calcium were significantly lower in cases
than controls (p = 0.002 and p ≤ 0.001, respectively). Cases
also had a significantly higher 25 (OH) vitamin D levels
than the controls (p < 0.001), although both groups fall
below sufficiency levels. Intact PTH was not significantly
different between groups. Table 2 shows the regression co-
efficients of the lipid parameters versus the different
thyroid tests, as well as 25(OH) vitamin D and PTH. A
significant positive association between HDL-cholesterol
and PTH (R = 0.56; p = 0.001) as well as a negative and
modestly significant association between LDL-cholesterol
and PTH were detected (R = - 20.0; p = 0.04). The rest of
the associations were not significant. Finally, Figure 1
shows the inverse and significant association between
FT3 and circulating 25 (OH) vitamin D (R = -0.25; p =
0.01). TSH was not significantly associated with 25(OH)
vitamin D.
Discussion
The main finding of this study is that aside from the
conventional and expected differences in the expressionFigure 1 Inverse association between FT3 and 25(OH) Vitamin D.of thyroid tests, including iodine and TPOab, patients with
hypothyroid dysfunction also exhibited obesity and ele-
vated levels of triglycerides as compared to controls. How
subclinical hypothyroid dysfunction influences weight gain
can be explained via the peripheral effects of thyroid hor-
mones and their local regulation of central nervous system
(CNS) in the physiologic regulation of appetite that is
independent of their conventional role in basal energy ex-
penditure as well as regulation of resting energy expend-
iture [8,9]. With respect to obesity per se, it has been
found out that visceral adipose tissue has a direct effect in
TSH levels among obese, and this is independent of insu-
lin resistance [10]. Regarding triglycerides, our results
were in accordance with the study of Wanjia and col-
leagues, who also observed elevated TSH levels among
patients with hypertriglyceridemia [11]. The exact mecha-
nisms accountable for the effects of thyroid function with
respect to lipid profile are unclear. Nevertheless it is al-
most established that TSH receptors are present in tissues
other than the thyroid gland which include kidneys, bone
marrow and adipose tissue, and that variations ion TSH
levels among euthyroid patients are partially explained by
lipid components and hypercholesterolemia which are
independent of thyroid hormones [12,13]. Furthermore,
there are several factors not accounted for in this study
that may influence thyroid function and lipid profile, in-
cluding smoking and insulin resistance [14], as well as
obesity and abnormalities in glucose tolerance.
One striking and unexpected finding in this study is
the significantly higher mean 25(OH) vitamin D levels
among patients with subclinical hypothyroid dysfunction
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factors for vitamin D deficiency including obesity and
hypetriglyceridemia [15-17]. Calcium levels while also
significantly different, still fall within normal range, al-
though the possibility of other causes such as malab-
sorption or decreased dietary calcium intake in some
subjects cannot be ruled out. Furthermore, PTH levels
were higher, although not significant in the case group
than controls. These differences this can be attributed to
several confounders unaccounted for in the study which
include differences in dietary calcium and vitamin D in-
take, undocumented comorbidities such as malabsorp-
tion and existing renal disorders which were not evident
at the time of selection, as well as sun exposure, and
needs further investigation. Nevertheless, while the vita-
min D status of cases was significantly higher as com-
pared to controls, both mean levels were still far below
sufficiency levels and the corresponding PTH levels
were not significantly different from one another, and as
such the interpretation is comparable. Furthermore we
recently observed that PTH levels do not correlate with
25(OH) vitamin D levels in Saudis despite severely low
levels [18].
The association of PTH with lipid concentrations, spe-
cifically the cholesterol levels was demonstrated earlier
and we suggest that this is mainly due to the positive
association of PTH to body composition and adiposity,
rather than the cholesterol itself [19,20]. Also, the in-
verse association of FT3 to circulating levels of 25(OH)
D should be interpreted with caution. It was previously
reported that higher vitamin D status was associated
with low TSH only among younger individuals and not
in adults [21]. Furthermore, while vitamin D deficiency
has been implicated in several autoimmune thyroid dis-
eases, no association was elicited between the antibodies
measured in the present study and vitamin D, confirming
a recent study among Dutch natives about the lack of cor-
relation of low vitamin D levels and the early stages of
thyroid auto-immunity [22]. Similarly, polymorphisms of
vitamin D alpha-hydroxylase (CYP)1alpha, a key enzyme
for regulating both systemic and tissue levels of 1, 25-
dihydroxyvitamin D3 [23], did not correlate with known
auto-immune disorders such as type 1 diabetes mellitus,
Grave’s disease and Hashimoto’s thyroidits among
Caucasian pedigrees [24]. In this context, it should be
taken into account that TSH may have direct and inde-
pendent effects on bone metabolism regardless of thy-
roid hormones [25,26].
The authors acknowledge several limitations. The
cross-sectional nature of the study and the small sample
size limits the findings of the study to at best, suggestive.
Several major confounders were also not included in-
cluding season which has a counterintuitive effect in the
vitamin D status of citizens residing in the Gulf region[27]. Gender difference could not be elicited due to the
big discrepancy in the numbers between male and female
subjects. Nevertheless, the study has its own strength as
being the first to document several metabolic differences
among Saudi patients with and without hypothyroid dys-
function and the first to associate vitamin D status in rela-
tion to thyroid function profile.
Conclusions
In summary, adult Saudi patients with subclinical hypo-
thyroid dysfunction harbor several cardiometabolic ab-
normalities, including obesity and dyslipidemia, the
latter being associated positively with PTH levels. Higher
vitamin D levels were associated with lower FT3 in the
patents. Further prospective studies are needed to deter-
mine whether the associations elicited are causal to one
another.
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